Contemporary OB-GYN: FDA approves-5-year-use-for-etonogestrel-implant-68-mg-contraceptive Safety Labeling Update for Nexplanon Patient Experiences with Nexplanon Summary of MedWatch Voluntary Reports for Nexplanon (240 reports of device complications for 1,577 reports submitted voluntarily, mainly by consumers) Rare Disease: FDA Approves First Treatment for Children With Menkes Disease The FDA approved the first-ever treatment for Menkes disease: Zydus Life Sciences Zycubo (copper histidinate) daily subcutaneous injection for pediatric patients
Features: The Semaglutide Injection Diabetes comes with salient features that make it unique in the market
Why Proper Reconstitution is Non-Negotiable Let's be direct
If your B12 is normal and you want to lose weight, choose strategies backed by trials or discuss medical options with your clinician
It suppresses antidiuretic hormone (ADH), causing your kidneys to excrete more water and electrolytes than they normally would
Sources Unleashing the power of retatrutide: A possible triumph over obesity and overweight: A correspondence PMC TripleHormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial New England Journal of Medicine Type 2 Diabetes Treatment to Lower A1C Mounjaro (tirzepatide) (lilly.com) Zepbound (tirzepatide) Injection for Adults with Obesity or Excess Weight (lilly.com) NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current
